TickerGuard
Buy Day today: Neutral (46) Mixed market breadth · no major macro event
MYO

Myomo Inc

Healthcare · Medical Devices

1.20$ -4.6% vs. previous close Closing price · As of: Oct 30, 2026

Ownership

Ownership Structure

Who owns Myomo Inc (MYO)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 70.1% of the shares are freely tradable; institutional investors hold 41.0%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 41.0%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 7.8%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 70.1%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 3.1%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 40Mio.

Largest Shareholders

No ownership data is available for this stock yet.

Insider holdings

Insider holdings MYO
Person Role Shares Value As of Type
Gudonis Paul R Chief Executive Officer 1,514,292 1,817,150 $ Oct 13, 2026 direct
Henry David A Chief Financial Officer 549,862 659,834 $ Oct 13, 2026 direct
McClure Mary-Katherine Hale Chief Commericial Officer 275,000 330,000 $ Oct 12, 2026 direct
Morris Milton Mayo Director 208,391 250,069 $ Sep 2, 2026 direct
Mitchell Micah Chief Commercial Officer 130,738 156,886 $ Aug 7, 2026 direct
Kovelman Harry Chief Medical Officer 122,389 146,867 $ Oct 13, 2026 direct

Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.

Insiders

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
Oct 13, 2026 Kovelman Harry Chief Medical Officer Other 32,500 0.00 –
Oct 13, 2026 Henry David A Chief Financial Officer Other 51,250 0.00 –
Oct 13, 2026 Gudonis Paul R Chief Executive Officer Other 71,250 0.00 –
Oct 12, 2026 Henry David A Chief Financial Officer Other 3,133 1.37 4,292
Oct 12, 2026 McClure Mary-Katherine Hale Chief Commericial Officer Other 275,000 0.00 –
Oct 9, 2026 Henry David A Chief Financial Officer Other 6,272 0.00 –
Oct 9, 2026 Gudonis Paul R Chief Executive Officer Other 8,363 0.00 –
Sep 11, 2026 Kovelman Harry Chief Medical Officer Sell 15,488 1.27 19,684
Sep 2, 2026 Morris Milton Mayo Director Sell 15,000 1.41 21,150
Aug 20, 2026 Kovelman Harry Chief Medical Officer Sell 17,250 1.73 29,896
Aug 7, 2026 Kovelman Harry Chief Medical Officer Other 22,457 1.42 31,889
Aug 7, 2026 Kovelman Harry Chief Medical Officer Other 55,149 0.00 –
Aug 7, 2026 Mitchell Micah Chief Commercial Officer Other 21,559 1.42 30,614
Aug 7, 2026 Mitchell Micah Chief Commercial Officer Other 58,409 0.00 –
Aug 7, 2026 Gudonis Paul R Chief Executive Officer Other 146,909 0.00 –
Aug 7, 2026 Henry David A Chief Financial Officer Other 25,310 1.42 35,940
Aug 7, 2026 Henry David A Chief Financial Officer Other 68,644 0.00 –
Jul 13, 2026 Henry David A Chief Financial Officer Other 5,166 1.09 5,631
Jul 10, 2026 Henry David A Chief Financial Officer Other 7,840 0.00 –
Jul 10, 2026 Gudonis Paul R Chief Executive Officer Other 10,454 0.00 –

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →

Data as of: October 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?